Pharmaceuticals & Biotechnology Editor | 03/20/2013
                                    
                    
                                                
	Robert Bronstein, Director Supply Operations at Macrogenics, speaks to Pharma IQ about the lack of visibility in the last mile of the supply chain and suggests ways the industry can overcome this. He also looks ahead to changes in regulations and how that will affect the Clinical Supply Chain.
	
	 
                    To continue reading this story Click Here
                                    
                            RECOMMENDED
Upcoming Events
Pharmaceutical Launch Excellence Summit
                            2 - 3 December, 2025
                            
 
                            UK
                            
                             Register Now |
                            View Agenda |
                            Learn More
                        
Pharma Contract Manufacturing
                            23 - 25 March 2026
                            
 
                            Mercure Hotel MOA Berlin, Germany
                            
                             Register Now |
                            View Agenda |
                            Learn More